Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin
Authors: Altaf Kassam1; Sandy D. Der2; Jeremy Mogridge
Source: Cellular Microbiology, Volume 7, Number 2, February 2005 , pp. 281-292(12)
Publisher: Blackwell Publishing
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Summary Anthrax lethal toxin (LT) is comprised of protective antigen and lethal factor. Lethal factor enters mammalian cells in a protective antigen-dependent process and cleaves mitogen-activated protein kinase kinases. Although LT has no observable effect on many cell types, it causes necrosis in macrophages derived from certain mouse strains and apoptosis in activated mouse macrophages. In this study, we observed that LT treatment of three different human monocytic cell lines U-937, HL-60 and THP-1 did not induce cell death. Cells did become susceptible to the toxin, however, after differentiation into a macrophage-like state. Treatment with LT resulted in decreased phosphorylation of p38, ERK1/2 and JNK in both undifferentiated and differentiated HL-60 cells, suggesting that the change in susceptibility does not result from differences in toxin delivery or substrate cleavage. Death of differentiated HL-60 cells was accompanied by chromosome condensation and DNA fragmentation, but was not inhibited by the pan-caspase inhibitor Z-VAD-FMK. In addition, we observed that the macrophage differentiation process could be inhibited by LT. Our results indicate that LT-mediated death of mouse and human macrophages may occur through distinct processes and that the differentiation state of human cells can determine susceptibility or resistance to LT.Document Type: Research article
DOI: 10.1111/j.1462-5822.2004.00458.x
Affiliations: 1: Department of Laboratory Medicine and Pathobiology, 2: Program in Proteomics and Bioinformatics, University of Toronto, Toronto M5S 1A8,
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content

Click here for Page Help